BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31450141)

  • 1. Letter to editor about "Affective symptoms and apathy in myotonic dystrophy type 1: A systematic review and meta-analysis".
    Heidari ME; Arabzadeh T; Eskandari F
    J Affect Disord; 2019 Dec; 259():316. PubMed ID: 31450141
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to the letter to editor about "Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis".
    Okkersen K; Raaphorst J
    J Affect Disord; 2019 Dec; 259():468-470. PubMed ID: 31609230
    [No Abstract]   [Full Text] [Related]  

  • 3. Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis.
    van der Velden BG; Okkersen K; Kessels RP; Groenewoud J; van Engelen B; Knoop H; Raaphorst J
    J Affect Disord; 2019 May; 250():260-269. PubMed ID: 30870776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy and hypersomnia are common features of myotonic dystrophy.
    Rubinsztein JS; Rubinsztein DC; Goodburn S; Holland AJ
    J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):510-5. PubMed ID: 9576545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of the Apathy Evaluation Scale in Myotonic Dystrophy Type 1.
    Gallais B; Gagnon C; Côté I; Forgues G; Laberge L
    J Neuromuscul Dis; 2018; 5(1):39-46. PubMed ID: 29278897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
    Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
    J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of apathy in myotonic dystrophy type 1.
    Gallais B; Montreuil M; Gargiulo M; Eymard B; Gagnon C; Laberge L
    BMC Neurol; 2015 Aug; 15():148. PubMed ID: 26296336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picturing the Experience of Living With Myotonic Dystrophy (DM1): A Qualitative Exploration Using Photovoice.
    LaDonna KA; Venance SL
    J Neurosci Nurs; 2015 Oct; 47(5):285-95. PubMed ID: 26348433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emotional and behavioral profile and child psychiatric diagnosis in the childhood type of myotonic dystrophy.
    Goossens E; Steyaert J; De Die-Smulders C; Willekens D; Fryns JP
    Genet Couns; 2000; 11(4):317-27. PubMed ID: 11140408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital myotonic dystrophy.
    Thompson A; Kaplan C; Gardner-Medwin D
    Pediatr Neurol; 1995 Jul; 13(1):85. PubMed ID: 7575859
    [No Abstract]   [Full Text] [Related]  

  • 11. Myotonic dystrophy: diagnosis, management and new therapies.
    Turner C; Hilton-Jones D
    Curr Opin Neurol; 2014 Oct; 27(5):599-606. PubMed ID: 25121518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglandular endocrinopathy in myotonic dystrophy: letter to editor.
    Zargar AH; Bhat MH; Ganie MA; Laway BA; Masoodi SR; Salahuddin M; Kour S
    Neurol India; 2002 Mar; 50(1):105-6. PubMed ID: 11960166
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current problems in myotonic dystrophy].
    Weglewski A; Juryńczyk J
    Neurol Neurochir Pol; 1998; 32(4):903-11. PubMed ID: 9864718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of myotonic dystrophy proved by DNA analysis].
    Juryńczyk J; Weglewski A
    Neurol Neurochir Pol; 1998; 32(5):1267-71. PubMed ID: 10463239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does abnormal neuronal excitability exist in myotonic dystrophy? II. Effects of the antiarrhythmic drug hydroquinidine on apathy and hypersomnia.
    Di Costanzo A; Mottola A; Toriello A; Di Iorio G; Tedeschi G; Bonavita V
    Neurol Sci; 2000 Apr; 21(2):81-6. PubMed ID: 10938185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of errorless learning on psychotic and affective symptoms, as well as aggression and apathy in patients with Korsakoff's syndrome in long-term care facilities.
    Rensen YCM; Egger JIM; Westhoff J; Walvoort SJW; Kessels RPC
    Int Psychogeriatr; 2019 Jan; 31(1):39-47. PubMed ID: 29923469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic Muscular Dystrophies.
    Johnson NE
    Continuum (Minneap Minn); 2019 Dec; 25(6):1682-1695. PubMed ID: 31794466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to the letter entitled "Predictors of respiratory impairment in patients with myotonic dystrophy type 1".
    Rossi S; Della Marca G; Ricci M; Perna A; Nicoletti TF; Brunetti V; Meleo E; Calvello M; Petrucci A; Antonini G; Bucci E; Licchelli L; Sancricca C; Massa R; Rastelli E; Botta A; Di Muzio A; Romano S; Garibaldi M; Silvestri G
    J Neurol Sci; 2019 Aug; 403():166-167. PubMed ID: 31153591
    [No Abstract]   [Full Text] [Related]  

  • 19. Myotonic dystrophies.
    Meola G
    Curr Opin Neurol; 2000 Oct; 13(5):519-25. PubMed ID: 11073357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic characteristics of childhood-onset myotonic dystrophy.
    Stokes M; Varughese N; Iannaccone S; Castro D
    Muscle Nerve; 2019 Dec; 60(6):732-738. PubMed ID: 31520483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.